Abstract
Hypertension is an important factor in cardiovascular diseases. Angiotensin-I-converting enzyme (ACE) inhibitors like synthetic drugs are widely used to control hypertension. ACE-inhibitory peptides from food origins could be a good alternative to synthetic drugs. A number of plant-based peptides have been investigated for their potential ACE inhibitor activities by using in vitro and in vivo assays. These plant-based peptides can be obtained by solvent extraction, enzymatic hydrolysis with or without novel food processing methods, and fermentation. ACE-inhibitory activities of peptides can be affected by their structural characteristics such as chain length, composition and sequence. ACE-inhibitory peptides should have gastrointestinal stability and reach the cardiovascular system to show their bioactivity. This paper reviews the current literature on plant-derived ACE-inhibitory peptides including their sources, production and structure, as well as their activity by in vitro and in vivo studies and their bioavailability.
Original language | English |
---|---|
Article number | 316 |
Journal | Nutrients |
Volume | 9 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Apr 2017 |
Bibliographical note
Publisher Copyright:© 2017 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- Angiotensin-I-converting enzyme inhibitory activity
- Bioactive peptides
- Bioavailability
- Diabetes
- Enzymatic hydrolysis
- Obesity
- Plant proteins